-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Reiterates Buy on Medline, Maintains $55 Price Target

Benzinga·07/31/2026 09:07:23
Listen to the news
BTIG analyst David Larsen reiterates Medline (NASDAQ:MDLN) with a Buy and maintains $55 price target.